Extending options for highly sensitized patients to receive a suitable kidney graft

Current Opinion in Immunology

Volumn 17, Issue 5, 2005, Pages 536-540

  Doxiadis, Ilias I N ^a   Duquesnoy, Rene J ^b   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN;

ABSORPTION; DESENSITIZATION; HISTOCOMPATIBILITY; HUMAN; IMMUNOADSORPTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MISMATCH REPAIR; REVIEW; SENSITIZATION; SURGICAL APPROACH;

HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION;

EID: 23944434761     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.07.010     Document Type: Review

References (53)

1. F. Kissmeyer-Nielsen, S. Olsen, V.P. Petersen, and O. Fjeldborg Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells Lancet 2 1966 662 665
2. R. Patel, and P.I. Terasaki Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 1969 735 739
3. I.I. Doxiadis, J.M. Smits, G.G. Persijn, U. Frei, and F.H. Claas It takes six to boogie: allocating cadaver kidneys in Eurotransplant Transplantation 77 2004 615 617 An explanation of the kidney allocation algorithm in Eurotransplant, including the acceptable mismatch program
4. F.H. Claas, L.P. de Waal, J. Beelen, P. Reekers, P.V. Berg-Loonen, E. de Gast, J. D'Amaro, G.G. Persijn, F. Zantvoort, and J.J. van Rood Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches Clin Transpl 1989 185 190
5. F.H. Claas, J. De Meester, M.D. Witvliet, J.M. Smits, G.G. Persijn, and I.I. Doxiadis Acceptable HLA mismatches for highly immunized patients Rev Immunogenet 1 1999 351 358
6. F.H. Claas, M.D. Witvliet, R.J. Duquesnoy, G.G. Persijn, and I.I. Doxiadis The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome Transplantation 78 2004 190 193 In this report the acceptable mismatch program applied in Eurotransplant and its perspectives are presented.
7. I.I. Doxiadis, J. De Meester, J.M. Smits, M. Witvliet, P. de Lange, G.G. Persijn, and F.H. Claas The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant Clin Transpl 1998 115 120
8. A. Palmer, D. Taube, K. Welsh, M. Bewick, P. Gjorstrup, and M. Thick Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation Lancet 1 1989 10 12
9. R.M. Hakim, E. Milford, J. Himmelfarb, R. Wingard, J.M. Lazarus, and R.M. Watt Extracorporeal removal of anti-HLA antibodies in transplant candidates Am J Kidney Dis 16 1990 423 431
10. M. Lorenz, H. Regele, M. Schillinger, J. Kletzmayr, B. Haidbauer, K. Derfler, W. Druml, and G.A. Bohmig Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients Transplantation 79 2005 696 701 This study presents new data on the use of immunoadsorption to remove HLA alloantibodies.
11. E. Akalin, S. Ames, V. Sehgal, B. Murphy, J.S. Bromberg, M. Fotino, and R. Friedlander Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients Transplantation 79 2005 742
12. E. Akalin, V. Sehgal, B. Murphy, E. Akalin, V. Sehgal, S. Ames, J.S. Bromberg, B. Murphy, S. Dikman, and M. Fotino Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy Transplantation 79 2005 257 258
13. D. Glotz, C. Antoine, and A. Duboust Antidonor antibodies and transplantation: how to deal with them before and after transplantation Transplantation 79 2005 S30 S32
14. D. Glotz, C. Antoine, P. Julia, B. Pegaz-Fiornet, A. Duboust, S. Boudjeltia, R. Fraoui, M. Combes, and J. Bariety Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies Transpl Int 17 2004 1 8
15. D. Glotz, C. Antoine, P. Julia, C. Suberbielle-Boissel, S. Boudjeltia, R. Fraoui, C. Hacen, A. Duboust, and J. Bariety Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg) Am J Transplant 2 2002 758 760
16. S.C. Jordan Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulin Am J Transplant 2 2002 691 692
17. S.C. Jordan, A.A. Vo, C.C. Nast, and D. Tyan Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience Clin Transpl 2003 193 198
18. S.C. Jordan, A. Vo, S. Bunnapradist, M. Toyoda, A. Peng, D. Puliyanda, E. Kamil, and D. Tyan Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 76 2003 631 636
19. S.C. Jordan, D. Tyan, D. Stablein, M. McIntosh, S. Rose, A. Vo, M. Toyoda, C. Davis, R. Shapiro, and D. Adey Evaluation of intravenous immunoglobulin as an agent to lower allosensitisation and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial J Am Soc Nephrol 15 2004 3256 3262 A description of a placebo controlled study on the use of IvIg. The study demonstrates that clinical application of the treatment is feasible for patients in different centres.
20. S.C. Jordan, A.A. Vo, M. Toyoda, D. Tyan, and C.C. Nast Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection Pediatr Transplant 9 2005 155 161
21. R.A. Montgomery, M. Cooper, E. Kraus, H. Rabb, M. Samaniego, C.E. Simpkins, C.J. Sonnenday, R.M. Ugarte, D.S. Warren, and A.A. Zachary Renal transplantation at the Johns Hopkins Comprehensive Transplant Center Clin Transpl 2003 199 213
22. R.A. Montgomery, and A.A. Zachary Transplanting patients with a positive donor-specific crossmatch: a single center's perspective Pediatr Transplant 8 2004 535 542 This study promotes the use of low doses of IvIg from a centre-specific perspective.
23. R.A. Montgomery, M.A. Hardy, S.C. Jordan, L.C. Racusen, L.E. Ratner, D.B. Tyan, and A.A. Zachary Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols Transplantation 78 2004 181 185 This publication presents useful and important information with respect to the IvIg treatment of sensitized patients from the point of view of the two major centres in the USA.
24. C.J. Sonnenday, L.E. Ratner, A.A. Zachary, J.F. Burdick, M.D. Samaniego, E. Kraus, D.S. Warren, and R.A. Montgomery Pre-emptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match Transplant Proc 34 2002 1614 1616
25. D.B. Tyan, V.A. Li, L. Czer, A. Trento, and S.C. Jordan Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ Transplantation 57 1994 553 562
26. M. Olausson, L. Mjornstedt, G. Norden, L. Rydberg, P. Lindner, L. Backman, and S. Friman Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients Transplant Proc 34 2002 3106 3107
27. A. Gutierrez, M. Crespo, J. Mila, J.V. Torregrosa, J. Martorell, and F. Oppenheimer Outcome of simultaneous liver-kidney transplantation in highly sensitized, crossmatch-positive patients Transplant Proc 35 2003 1861 1862
28. S.V. Fuggle, and S. Martin Toward performing transplantation in highly sensitized patients Transplantation 78 2004 186 189
29. J.B. Bussel, and M.W. Hilgartner The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease Br J Haematol 56 1984 1 7
30. S.C. Jordan, A.W. Quartel, L.S. Czer, D. Admon, G. Chen, M.C. Fishbein, J. Schwieger, R.W. Steiner, C. Davis, and D.B. Tyan Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66 1998 800 805
31. V. Moger, M.S. Ravishankar, V. Sakhuja, H.S. Kohli, K. Sud, K.L. Gupta, and V. Jha Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection Transplantation 77 2004 1455 1456
32. N.B. White, S.M. Greenstein, A.W. Cantafio, R. Schechner, D. Glicklich, P. McDonough, J. Pullman, K. Mohandas, F. Boctor, J. Uehlinger, and V. Tellis Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection Transplantation 78 2004 772 774
33. C. Sammartino, T. Pham, F. Panaro, D. Bogetti, T. Jarzembowski, H. Sankary, N. Morelli, G. Testa, and E. Benedetti Successful simultaneous pancreas kidney transplantation from living-related donor against positive cross-match Am J Transplant 4 2004 140 143
34. S.H. Leech, S. Rubin, H.J. Eisen, P.J. Mather, B.I. Goldman, J.B. McClurken, and S. Furukawa Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients Clin Transplant 17 Suppl 9 2003 17 26
35. L.K. Kayler, B. Colombe, J.L. Farber, D. Lacava, D.C. Dafoe, J.F. Burke, G.C. Francos, and L.E. Ratner Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch Clin Transplant 18 2004 737 742
36. K.E. King, D.S. Warren, M. Samaniego-Picota, S. Campbell-Lee, R.A. Montgomery, and W.M. Baldwin III Antibody, complement and accommodation in ABO-incompatible transplants Curr Opin Immunol 16 2004 545 549
37. D.S. Warren, A.A. Zachary, C.J. Sonnenday, K.E. King, M. Cooper, L.E. Ratner, R.S. Shirey, M. Haas, M.S. Leffell, and R.A. Montgomery Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers Am J Transplant 4 2004 561 568
38. G. Tyden, G. Kumlien, H. Genberg, J. Sandberg, T. Lundgren, and I. Fehrman ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab Am J Transplant 5 2005 145 148
39. A.A. Zachary, R.A. Montgomery, L.E. Ratner, M. Samaniego-Picota, M. Haas, D. Kopchaliiska, and M.S. Leffell Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients Transplantation 76 2003 1519 1525
40. K. Mahmoud, M. Sobh, F. El Shenawy, A. Mostafa, E.M. Abo, N. Hassan, A. El Agroudy, H. Sheashaa, G. Opelz, and M. Ghoneim Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against HLA in highly sensitized transplant candidates Transplant Proc 36 2004 1850 1852
41. R. Wassmuth, I.A. Hauser, K. Schuler, H. Erxleben, M.L. Arnold, C.A. Koelman, F.H. Claas, and J.R. Kalden Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro Transplantation 71 2001 1436 1442
42. M. Toyoda, A. Pao, A. Petrosian, and S.C. Jordan Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells Am J Transplant 3 2003 156 166
43. K.S. Sivasai, T. Mohanakumar, D. Phelan, S. Martin, M.E. Anstey, and D.C. Brennan Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates Clin Exp Immunol 119 2000 559 565
44. M. Toyoda, A. Petrosyan, A. Pao, and S.C. Jordan Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction Transplantation 78 2004 1134 1138
45. B.J. Gallay, R.V. Perez, and R. Ramsamooj Acute renal transplant injury and interaction between antithymocyte globulin and pooled human immunoglobulin Clin Transplant 18 2004 327 331
46. M. Haas, C.J. Sonnenday, J.S. Cicone, H. Rabb, and R.A. Montgomery Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch Transplantation 78 2004 549 556
47. J.M. Gloor, S. DeGoey, N. Ploeger, H. Gebel, R. Bray, S.B. Moore, P.G. Dean, and M.D. Stegall Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation Transplantation 78 2004 221 227 This report clearly demonstrates the persistence of the donor HLA-specific antibodies in patients after IvIg treatment. These antibodies can cause late graft loss via chronic rejection.
48. Y.M. Zoet, C. Eijsink, M.J. Kardol, Franke-van Dijk MEI, G.L. Wilson, R. de Paus, E. Mickelson, M. Heemskerk, P.J. van der Elsen, and FH.J. Claas The Single Antigen expressing Lines (SALs) concept: An excellent tool for the screening for HLA specific antibodies Hum Immunol 66 2005 519 525
49. R. Pei, J.H. Lee, N.J. Shih, M. Chen, and P.I. Terasaki Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities Transplantation 75 2003 43 49
50. R.J. Duquesnoy HLAMatchmaker: a molecularly based algorithm for histocompatibility determination I. Description of the algorithm Hum Immunol 63 2002 339 352
51. R.J. Duquesnoy, M. Witvliet, I.I. Doxiadis, H. de Fijter, and F.H. Claas HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates Transpl Int 17 2004 22 30 This report presents experimental evidence of the theoretical approach of the HLAMatchmaker concept.
52. S.L. Saidman, R.J. Duquesnoy, A.J. Demetris, J. McCauley, H. Ramos, G. Mazariegos, R. Shapiro, T.E. Starzl, and J.J. Fung Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies Transpl Immunol 2 1994 61 67
53. J.P. Vella, D. O'Neill, N. Atkins, J.F. Donohoe, and J.J. Walshe Sensitization to human leukocyte antigen before and after the introduction of erythropoietin Nephrol Dial Transplant 13 1998 2027 2032